Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$155.97 - $200.09 $43,515 - $55,825
-279 Closed
0 $0
Q1 2022

Apr 20, 2022

SELL
$181.39 - $234.03 $5,985 - $7,722
-33 Reduced 10.58%
279 $52,000
Q2 2021

Jul 23, 2021

BUY
$155.9 - $187.99 $1,559 - $1,879
10 Added 3.31%
312 $58,000
Q4 2020

Jan 28, 2021

SELL
$157.07 - $174.35 $4,869 - $5,404
-31 Reduced 9.31%
302 $50,000
Q4 2019

Jan 17, 2020

SELL
$116.25 - $133.25 $2,906 - $3,331
-25 Reduced 6.98%
333 $44,000
Q2 2019

Jul 18, 2019

BUY
$97.98 - $114.28 $19,596 - $22,856
200 Added 126.58%
358 $41,000
Q3 2017

Oct 12, 2017

BUY
$59.73 - $65.4 $9,437 - $10,333
158
158 $10,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Gemmer Asset Management LLC Portfolio

Follow Gemmer Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gemmer Asset Management LLC with notifications on news.